Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: Prevalence, natural history, and thyrotropin receptor antibody levels

Thyroid

Volumn 10, Issue 12, 2000, Pages 1093-1100

  Khoo, D H ^a   Eng, P H ^a   Ho, S C ^a   Tai, E S ^a   Morgenthaler, N G ^b   Seah, L L ^a   Fong, K S ^a   Chee, S P ^a   Choo, C T ^a   Aw, S E ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b Biotechnology Centre Hennigsdorf   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; MACROGOL; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; GRAVES DISEASE; HORMONE DETERMINATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; PREVALENCE; PRIORITY JOURNAL; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL;

EID: 0034500742     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2000.10.1093     Document Type: Article

References (47)

1. Graves' ophthalmopathy: Current concepts regarding pathogenesis and management
2. Clinical features of Graves' ophthalmopathy in an incidence cohort
3. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders
4. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy
5. Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue
6. Eyeing up Graves' ophthalmopathy
7. The thyrotropin receptor in thyroid eye disease
8. Has the target autoantigen for Graves' ophthalmopathy been found?
9. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: Potential autoantigen in Graves' ophthalmopathy
10. Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin
11. Development of an animal model of autoimmune thyroid eye disease
12. Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease
13. Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor
14. TSH receptor antibodies in Graves' ophthalmopathy: High association and predictive role of thyroid stimulating but not TSH binding inhibitory antibodies
15. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease
16. The combination of absent thyroid peroxidase antibodies and high thyroid stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy
17. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy
18. Value of thyroid stimulating antibody in the diagnosis of thyroid associated ophthalmopathy of euthyroid patients
19. Comparison of thyroid stimulating activities measured by cyclic AMP production, those by radioiodine uptake in FRTL-5 cells and TSH-binding inhibitory activities in patients with hyperthyroid and euthyroid Graves' diseases
20. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease
21. Thyrotropin receptor antibodies in hypothyroid Graves' disease
22. The thyrotropin (TSH) receptor: Interaction with TSH and autoantibodies
23. New assay systems for thyrotropin receptor antibodies
24. Measurement of thyroid stimulating immunoglobulins in a new cell line transfected with a functional human TSH receptor (JPO9 cells), compared with an assay using FRTL-5 cells
25. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor
26. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease
27. Comparison of recombinant human thyrotropin receptors versus porcine thyrotropin receptors in the thyrotropin binding inhibition assay for thyrotropin receptor autoantibodies
28. Diagnostic criteria for Graves' ophthalmopathy
29. Technical evaluation of thyroid assays on the Vitros ECi
30. Differences in the levels of TSH-binding inhibitor immunoglobulins in goitrous and agoitrous autoimmune thyroiditis after twelve months of L-thyroxine therapy
31. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor
32. Production of bioactive amino-terminal domain of the thyrotropin receptor via insertion in the plasma membrane by a glycosylphosphatidylinositol anchor
33. Clinical experience with a human thyroid cell bioassay for thyroid-stimulating immunoglobulin
34. Severe thyroid eye disease, associated with primary hypothyroidism and thyroid-associated dermopathy
35. Goitrous hypothyroidism with blocking or stimulating thyrotropin binding inhibitor immunoglobulins
36. Significance of thyroid stimulating antibody and long-term follow-up in patients with euthyroid Graves' disease
37. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease
38. Similarity and dissimilarity between clinical and laboratory findings, especially anti-thyrotropin receptor antibody in ophthalmic Graves' disease without persistent hyperthyroidism and hyperthyroid Graves' disease
39. Clinical significance of a sensitive assay for thyroid-stimulating antibodies in Graves' disease using polyethylene glycol at high concentrations and porcine thyroid cells
40. Clinical usefulness of TSAb assay with high polyethylene glycol concentrations
41. Augmentation of thyroid-stimulating antibody-stimulated cyclic adenosine monophosphate response by polyethylene glycol, polyvinyl alcohol, and dextran: Highly sensitive porcine thyroid cell thyroid-stimulating antibody assay
42. Increase of thyroid-stimulating activity in Graves' immunogobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay
43. Bioassay of TSH using dog thyroid cells in monolayer culture
44. Clinical utility of thyrotropin-receptor antibody assays: Comparison of radioreceptor and bioassay methods
45. Clinical significance of assay of thyroid-stimulating antibody in Graves' disease
46. Bioassay of thyroid-stimulating immunoglobulins using human thyroid cell cultures: Optimization and clinical assessment
47. Thyrotoxicosis due to the simultaneous occurrence of silent thyroiditis and Graves' disease